← SynDRA
MEDETOMIDINE
SynDRA canonical compound SYN0003243 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ADRA2C |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
| Indication | sedative |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- ADRA2A
- ADRA2B
- ADRA2C
- ADRA1A
- ADRA1B
- ADRA1D
- Adra1a
- Adra1b
- Adra1d
- Adra2a
- Adra2b
- Adra2c
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRA2A AGONIST
- ADRA2A PARTIAL AGONIST
- ADRA2B FULL AGONIST
- ADRA2C AGONIST
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Analgesics
- Analgesics, Non-Narcotic
- Central Nervous System Agents
- Central Nervous System Depressants
- Hypnotics and Sedatives
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sensory System Agents
Cross-references
Synonyms
- medetomidine hydrochloride
- (+/-)-Medetomidine
- dl-Medetomidine
- medetomidine HCl
- Medetomidina
- Domitor
- MR15E85MQM
- 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, (+-)-
- (+-)-4-(alpha,2,3-trimethylbenzyl)imidazole
- Medetomidinum
- 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
- CHEBI:48552
- 5-(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole
- RefChem:56412
- IH-Imidazole, 4(1-(2,3-dimethylphenyl)ethyl)-
- DTXCID1028233
- 4-(1-(2,3-Dimethylphenyl)ethyl)-1H-imidazole
- 4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
- Medetomidinum [Latin]
- Medetomidina [Spanish]
- 1H-Imidazole, 4-[1-(2,3-dimethylphenyl)ethyl]-
- Medetomidine (INN)
- MEDETOMIDINE [INN]
- 1H-Imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-
- Medetomidine [INN:BAN]
- UNII-MR15E85MQM
- (RS)-4-(alpha,2,3-Trimethylbenzyl)imidazol
- MFCD00864346
- MEDETOMIDINE [MI]
- Dexmedetomidine Impurity 38
- Domitor [veterinary] (TN)
- SCHEMBL26432
- SCHEMBL787407
- orb1909168
- SCHEMBL29945090
- MEDETOMIDINE [GREEN BOOK]
- HMS3651H20
- HMS5081O12
Look up MEDETOMIDINE in the interactive SynDRA portal →